Viatris Pharmaceuticals LLCJanuary 26, 2018

FDA 483 - Viatris Pharmaceuticals LLC - January 26, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Viatris Pharmaceuticals LLC

Record Details

Pfizer Pharmaceuticals LLC in Vega Baja, PR, was cited for failing to thoroughly review unexplained discrepancies during an inspection from January 10-26, 2018. Specifically, the firm did not adequately investigate critical defects like broken Nitrostat tablets in distributed lots. The investigation was incomplete, as it failed to evaluate manufacturing process parameters and lacked proper user permission controls for critical system parameters.

Company: Viatris Pharmaceuticals LLC
Inspection Date: January 26, 2018
Product Type: Drugs
Office: Division of Human and Animal Food Operations - East IV
People: Jose F. Velez
Marian E. Ramirez (investigator)

Open in Dashboard

ID · 42243cff-6684-4015-8c0e-a3a388ed6dc4